Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
ItalyStudy on Lasmiditan for Treating Migraine in Children Aged 6 to 17
ItalyStudy of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer
ItalyStudy on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and TYPE 3 Spinal Muscular Atrophy Who Completed Previous Trials
ItalyStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
ItalyStudy on the Effectiveness of Chloroprocaine Gel and Oxybuprocaine Drops for Eye Anesthesia in Children Needing Eye Exams
ItalyStudy of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma
ItalyStudy on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination
ItalyStudy on the Effectiveness of Inebilizumab for Patients with IgG4-Related Disease
ItalyStudy on the Effectiveness and Safety of Pembrolizumab, Quavonlimab, and Lenvatinib for Patients with Advanced Small Cell Lung Cancer Needing Second-Line Treatment
ItalyStudy Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera
ItalyStudy comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
